{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:15:22Z","timestamp":1791411322792,"version":"4.3.3"},"reference-count":57,"publisher":"MathDoc\/Centre Mersenne","issue":"3","content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p id=\"spar0005\">\n                    Gene therapy is quickly becoming a reality applicable in the clinic for inherited retinal diseases. Progress over the past decade has moved proof-of-concept gene therapies from bench to bedside. The remarkable success in safety and efficacy, in the phase I\/II clinical trials for the form of the severe childhood-onset blindness, Leber's Congenital Amaurosis (LCA) type II (due to mutations in the\n                    <jats:italic>RPE65<\/jats:italic>\n                    gene) generated significant interest and opened up possibilities for a new era of retinal gene therapies. Success in these clinical trials was due to combining the favorable features of both the retina as a target organ and adeno-associated virus (AAV) as a vector. The retina offers several advantages for gene therapy approaches. It is an anatomically defined structure that is readily accessible for therapy and has some degree of immune privilege, making it suitable for application of viral vectors. AAV, on the other hand, is a non-pathogenic helper dependent virus that has little immunogenicity. This viral vector transduces quiescent cells efficiently and thanks to its small size diffuses well in the interneural matrix, making it suitable for applications in neural tissue. Building on this initial clinical success with LCA II, we have now many opportunities to extend this proof-of-concept to other retinal diseases. This article will discuss what are some of the most imminent targets for such therapies and what are the challenges that we face in moving these therapies to the clinic.\n                  <\/jats:p>","DOI":"10.1016\/j.crvi.2014.01.002","type":"journal-article","created":{"date-parts":[[2014,3,13]],"date-time":"2014-03-13T03:01:30Z","timestamp":1394679690000},"page":"185-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Gene therapy for inherited retinal degenerations"],"prefix":"10.5802","volume":"337","author":[{"given":"Deniz","family":"Dalkara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Alain","family":"Sahel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3842","published-online":{"date-parts":[[2014,3,1]]},"reference":[{"key":"key2025102316374033925_1","first-page":"1","author":"Smith, A.J.","year":"2011","unstructured":"[1] Smith, A.J.; Bainbridge, J.W.B.; Ali, R.R. Gene supplementation therapy for recessive forms of inherited retinal dystrophies (2011), pp. 1-8 (10.1038\/gt.2011.161)","journal-title":"Gene supplementation therapy for recessive forms of inherited retinal dystrophies"},{"key":"key2025102316374033925_2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/mt.2012.280","article-title":"A comprehensive review of retinal gene therapy","volume":"21","author":"Boye, S.E.","year":"2013","unstructured":"[2] Boye, S.E.; Boye, S.L.; Lewin, A.S.; Hauswirth, W.W. A comprehensive review of retinal gene therapy, Mol. Ther., Volume 21 (2013), pp. 509-519","journal-title":"Mol. Ther."},{"key":"key2025102316374033925_3","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber's congenital amaurosis","volume":"358","author":"Bainbridge, J.W.B.","year":"2014","unstructured":"[3] Bainbridge, J.W.B. et al. Effect of gene therapy on visual function in Leber's congenital amaurosis, New Engl. J. Med., Volume 358 (2014), pp. 2231-2239","journal-title":"New Engl. J. Med."},{"key":"key2025102316374033925_4","author":"Cideciyan, A.V.","year":"2008","unstructured":"[4] Cideciyan, A.V.; Aleman, T.S.; Boye, S.L. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics, 2008","journal-title":"Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics"},{"key":"key2025102316374033925_5","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber's congenital amaurosis","volume":"358","author":"Maguire, A.M.","year":"2008","unstructured":"[5] Maguire, A.M. et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis, New Engl. J. Med., Volume 358 (2008), pp. 2240-2248","journal-title":"New Engl. J. Med."},{"key":"key2025102316374033925_6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1126\/scitranslmed.3002865","article-title":"AAV2 gene therapy readministration in three adults with congenital blindness","volume":"4","author":"Bennett, J.","year":"2012","unstructured":"[6] Bennett, J. et al. AAV2 gene therapy readministration in three adults with congenital blindness, Sci. Transl. Med., Volume 4 (2012), pp. 15-120","journal-title":"Sci. Transl. Med."},{"key":"key2025102316374033925_7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/archophthalmol.2011.298","article-title":"Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years","volume":"130","author":"Jacobson, S.G.","year":"2012","unstructured":"[7] Jacobson, S.G. et al. Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years, Arch. Ophthalmol., Volume 130 (2012), pp. 9-24","journal-title":"Arch. Ophthalmol."},{"key":"key2025102316374033925_8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0022-5320(79)80014-3","article-title":"The relationship of primate foveal cones to the pigment epithelium","volume":"67","author":"Anderson, D.H.","year":"1979","unstructured":"[8] Anderson, D.H.; Fisher, S.K. The relationship of primate foveal cones to the pigment epithelium, J. Ultrastructure Res., Volume 67 (1979), pp. 23-32","journal-title":"J. Ultrastructure Res."},{"key":"key2025102316374033925_9","doi-asserted-by":"crossref","first-page":"E517","DOI":"10.1073\/pnas.1218933110","article-title":"Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement","volume":"110","author":"Cideciyan, A.V.","year":"2013","unstructured":"[9] Cideciyan, A.V. et al. Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement, Proc. Natl. Acad. Sci. USA, Volume 110 (2013), p. E517-E525","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key2025102316374033925_10","author":"Herrero-Vanrell, R.","year":"2011","unstructured":"[10] Herrero-Vanrell, R. Microparticles as drug delivery systems for the back of the eye. Drug product development for the back of the eye, 2011","journal-title":"Microparticles as drug delivery systems for the back of the eye. Drug product development for the back of the eye"},{"key":"key2025102316374033925_11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.preteyeres.2010.04.004","article-title":"Nanoparticles for retinal gene therapy","volume":"29","author":"Conley, S.M.","year":"2010","unstructured":"[11] Conley, S.M.; Naash, M.I. Nanoparticles for retinal gene therapy, Prog. Retinal Eye Res., Volume 29 (2010), pp. 376-397","journal-title":"Prog. Retinal Eye Res."},{"key":"key2025102316374033925_12","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/mt.2009.181","article-title":"Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous","volume":"17","author":"Dalkara, D.","year":"2009","unstructured":"[12] Dalkara, D. et al. Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous, Mol. Ther., Volume 17 (2009), pp. 2096-2102","journal-title":"Mol. Ther."},{"key":"key2025102316374033925_13","article-title":"Ocular gene therapy: a review of non-viral strategies","author":"Andrieu-Soler, C.","year":"2006","unstructured":"[13] Andrieu-Soler, C.; Bejjani, R.A.; de Bizemont, T. Ocular gene therapy: a review of non-viral strategies, Mol. Vis. (2006)","journal-title":"Mol. Vis."},{"key":"key2025102316374033925_14","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1167\/iovs.10-6916","article-title":"DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects","volume":"52","author":"Han, Z.","year":"2011","unstructured":"[14] Han, Z.; Conley, S.M.; Naash, M.I.; Compacted, A.A.V. DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects, Invest. Ophthalmol. Vis. Sci., Volume 52 (2011), pp. 3051-3059","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"key2025102316374033925_15","doi-asserted-by":"crossref","first-page":"7158","DOI":"10.1016\/j.biomaterials.2013.06.002","article-title":"A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium","volume":"34","author":"Koirala, A.","year":"2013","unstructured":"[15] Koirala, A.; Conley, S.M.; Naash, M.I. A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium, Biomaterials, Volume 34 (2013), pp. 7158-7167","journal-title":"Biomaterials"},{"key":"key2025102316374033925_16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.visres.2007.07.012","article-title":"Nanoparticle applications in ocular gene therapy","volume":"48","author":"Cai, X.","year":"2008","unstructured":"[16] Cai, X.; Conley, S.; Naash, M. Nanoparticle applications in ocular gene therapy, Vis. Res., Volume 48 (2008), pp. 319-324","journal-title":"Vis. Res."},{"key":"key2025102316374033925_17","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1172\/JCI64833","article-title":"DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice","volume":"122","author":"Han, Z.","year":"2012","unstructured":"[17] Han, Z.; Conley, S.M.; Makkia, R.S.; Cooper, M.J.; Naash, M.I. DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice, J. Clin. Invest., Volume 122 (2012), pp. 3221-3226","journal-title":"J. Clin. Invest."},{"key":"key2025102316374033925_18","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.visres.2008.05.005","article-title":"Barriers for retinal gene therapy: separating fact from fiction","volume":"48","author":"Kumar-Singh, R.","year":"2008","unstructured":"[18] Kumar-Singh, R. Barriers for retinal gene therapy: separating fact from fiction, Vis. Res., Volume 48 (2008), pp. 1671-1680","journal-title":"Vis. Res."},{"key":"key2025102316374033925_19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/gt.2011.153","article-title":"Ocular gene delivery using lentiviral vectors","volume":"19","author":"Balaggan, K.S.","year":"2012","unstructured":"[19] Balaggan, K.S.; Ali, R.R. Ocular gene delivery using lentiviral vectors, Gene Ther., Volume 19 (2012), pp. 145-153","journal-title":"Gene Ther."},{"key":"key2025102316374033925_20","first-page":"1","author":"Vandenberghe, L.H.","year":"2011","unstructured":"[20] Vandenberghe, L.H.; Auricchio, A. Novel adeno-associated viral vectors for retinal gene therapy (2011), pp. 1-7","journal-title":"Novel adeno-associated viral vectors for retinal gene therapy"},{"key":"key2025102316374033925_21","doi-asserted-by":"crossref","DOI":"10.1007\/BF02150029","article-title":"Structure and composition of the inner limiting membrane of the retina","author":"Heegaard, S.","year":"1986","unstructured":"[21] Heegaard, S.; Jensen, O.A.; Prause, J.U. Structure and composition of the inner limiting membrane of the retina, Graefe's Arch. Clin. Exp. Ophthalmol. (1986)","journal-title":"Graefe's Arch. Clin. Exp. Ophthalmol."},{"key":"key2025102316374033925_22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/09273948.2010.512696","article-title":"Review of ocular immune privilege in the year 2010: modifying the immune privilege of the eye","volume":"18","author":"Hori, J.","year":"2010","unstructured":"[22] Hori, J.; Vega, J.L.; Masli, S. Review of ocular immune privilege in the year 2010: modifying the immune privilege of the eye, Occult. Immunol. Inflamm., Volume 18 (2010), pp. 325-333","journal-title":"Occult. Immunol. Inflamm."},{"key":"key2025102316374033925_23","first-page":"267","article-title":"Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye","volume":"15","author":"Li, W.","year":"2009","unstructured":"[23] Li, W. et al. Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye, Mol. Vis., Volume 15 (2009), pp. 267-275","journal-title":"Mol. Vis."},{"key":"key2025102316374033925_24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/mt.2008.269","article-title":"High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors","volume":"17","author":"Petrs-Silva, H.","year":"2009","unstructured":"[24] Petrs-Silva, H. et al. High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors, Mol. Ther., Volume 17 (2009), pp. 463-471","journal-title":"Mol. Ther."},{"key":"key2025102316374033925_25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/scitranslmed.3005708","article-title":"In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous","volume":"5","author":"Dalkara, D.","year":"2013","unstructured":"[25] Dalkara, D. et al. In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous, Sci. Transl. Med., Volume 5 (2013), pp. 76-189","journal-title":"Sci. Transl. Med."},{"key":"key2025102316374033925_26","author":"Boye, S.E.","year":"2013","unstructured":"[26] Boye, S.E. Transduction of the outer retina. In ARVO Meeting Abstracts, 2013","journal-title":"Transduction of the outer retina. In ARVO Meeting Abstracts"},{"key":"key2025102316374033925_27","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1167\/iovs.10-6250","article-title":"Intravitreal injection of AAV2 transduces macaque inner retina","volume":"52","author":"Yin, L.","year":"2011","unstructured":"[27] Yin, L. et al. Intravitreal injection of AAV2 transduces macaque inner retina, Invest. Ophthalmol. Vis. Sci., Volume 52 (2011), pp. 2775-2783","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"key2025102316374033925_28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molmed.2005.02.007","article-title":"Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy","volume":"11","author":"Mendes, H.F.","year":"2005","unstructured":"[28] Mendes, H.F.; van der Spuy, J.; Chapple, J.P.; Cheetham, M.E. Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy, Trends Mol. Med., Volume 11 (2005), pp. 177-185","journal-title":"Trends Mol. Med."},{"key":"key2025102316374033925_29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/hum.2010.140","article-title":"AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa","volume":"22","author":"Mao, H.","year":"2011","unstructured":"[29] Mao, H. et al. AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa, Hum. Gene Ther., Volume 22 (2011), pp. 567-575","journal-title":"Hum. Gene Ther."},{"key":"key2025102316374033925_30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/mthe.2001.0473","article-title":"Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa","volume":"4","author":"Liang, F.Q.","year":"2001","unstructured":"[30] Liang, F.Q. et al. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa, Mol. Ther., Volume 4 (2001), pp. 461-472","journal-title":"Mol. Ther."},{"key":"key2025102316374033925_31","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1523\/JNEUROSCI.23-10-04164.2003","article-title":"Increased expression of brain-derived neurotrophic factor preserves retinal function and slows cell death from rhodopsin mutation or oxidative damage","volume":"23","author":"Okoye, G.","year":"2003","unstructured":"[31] Okoye, G. et al. Increased expression of brain-derived neurotrophic factor preserves retinal function and slows cell death from rhodopsin mutation or oxidative damage, J. Neurosci., Volume 23 (2003), pp. 4164-4172","journal-title":"J. Neurosci."},{"key":"key2025102316374033925_32","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ymthe.2006.05.019","article-title":"In contrast to AAV-mediated Cntf expression AAV-mediated Gdnf expression enhances gene replacement therapy in rodent models of retinal degeneration","volume":"14","author":"Buch, P.K.","year":"2006","unstructured":"[32] Buch, P.K. et al. In contrast to AAV-mediated Cntf expression AAV-mediated Gdnf expression enhances gene replacement therapy in rodent models of retinal degeneration, Mol. Ther., Volume 14 (2006), pp. 700-709","journal-title":"Mol. Ther."},{"key":"key2025102316374033925_33","doi-asserted-by":"crossref","DOI":"10.1038\/mt.2011.62","article-title":"AAV mediated GDNF secretion from retinal glia slows down retinal degeneration in a rat model of retinitis pigmentosa","author":"Dalkara, D.","year":"2011","unstructured":"[33] Dalkara, D. et al. AAV mediated GDNF secretion from retinal glia slows down retinal degeneration in a rat model of retinitis pigmentosa, Mol. Ther. (2011)","journal-title":"Mol. Ther."},{"key":"key2025102316374033925_34","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1006\/mthe.2001.0498","article-title":"Glial Cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa","volume":"4","author":"Sanftner, L.H.M.","year":"2001","unstructured":"[34] Sanftner, L.H.M.; Abel, H.; Hauswirth, W.W.; Flannery, J.G. Glial Cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa, Mol. Ther., Volume 4 (2001), pp. 622-629","journal-title":"Mol. Ther."},{"key":"key2025102316374033925_35","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.11-7996","article-title":"Assessment of cone survival in response to CNTF, GDNF, and VEGF165b in a novel ex vivo model of end-stage retinitis pigmentosa","author":"Lipinski, D.M.","year":"2011","unstructured":"[35] Lipinski, D.M.; Singh, M.S.; MacLaren, R.E. Assessment of cone survival in response to CNTF, GDNF, and VEGF165b in a novel ex vivo model of end-stage retinitis pigmentosa, Invest. Ophthalmol. Vis. (2011)","journal-title":"Invest. Ophthalmol. Vis."},{"key":"key2025102316374033925_36","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1073\/pnas.93.14.7042","article-title":"Bcl-2 overexpression reduces apoptotic photoreceptor cell death in three different retinal degenerations","volume":"93","author":"Chen, J.","year":"1996","unstructured":"[36] Chen, J. et al. Bcl-2 overexpression reduces apoptotic photoreceptor cell death in three different retinal degenerations, Proc. Natl. Acad. Sci. USA, Volume 93 (1996), pp. 7042-7047","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key2025102316374033925_37","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1371\/journal.pone.0000314","article-title":"XIAP protection of photoreceptors in animal models of retinitis pigmentosa","volume":"2","author":"Leonard, K.C.","year":"2007","unstructured":"[37] Leonard, K.C. et al. XIAP protection of photoreceptors in animal models of retinitis pigmentosa, PloS one, Volume 2 (2007), p. e314","journal-title":"PloS one"},{"key":"key2025102316374033925_38","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.1167\/iovs.10-6850","article-title":"AAV-mediated gene transfer of human X-linked inhibitor of apoptosis protects against oxidative cell death in human, RPE, cells","volume":"52","year":"2011","unstructured":"[38]  AAV-mediated gene transfer of human X-linked inhibitor of apoptosis protects against oxidative cell death in human, RPE, cells, Invest. Ophthalmol. Vis. Sci., Volume 52 (2011), pp. 9591-9597","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"key2025102316374033925_39","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-2855","article-title":"Effects on XIAP retinal detachment-induced photoreceptor apoptosis","author":"Zadro-Lamoureux, L.A.","year":"2009","unstructured":"[39] Zadro-Lamoureux, L.A.; Zacks, D.N.; Baker, A.N. Effects on XIAP retinal detachment-induced photoreceptor apoptosis, Ophthalmol. Vis. (2009)","journal-title":"Ophthalmol. Vis."},{"key":"key2025102316374033925_40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1126\/scitranslmed.3000866","article-title":"Rod-derived cone viability factor for treating blinding diseases: from clinic to redox signaling","volume":"2","author":"L\u00e9veillard, T.","year":"2010","unstructured":"[40] L\u00e9veillard, T.; Sahel, J.-A. Rod-derived cone viability factor for treating blinding diseases: from clinic to redox signaling, Sci. Transl. Med., Volume 2 (2010), pp. 16-26","journal-title":"Sci. Transl. Med."},{"key":"key2025102316374033925_41","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1523\/JNEUROSCI.15-08-05429.1995","article-title":"Rod photoreceptor neurite sprouting in retinitis pigmentosa","volume":"15","author":"Li, Z.Y.","year":"1995","unstructured":"[41] Li, Z.Y.; Kljavin, I.J.; Milam, A.H. Rod photoreceptor neurite sprouting in retinitis pigmentosa, J. Neurosci., Volume 15 (1995), pp. 5429-5438","journal-title":"J. Neurosci."},{"key":"key2025102316374033925_42","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/ng1386","article-title":"Identification and characterization of rod-derived cone viability factor","volume":"36","author":"L\u00e9veillard, T.","year":"2004","unstructured":"[42] L\u00e9veillard, T. et al. Identification and characterization of rod-derived cone viability factor, Nat. Genet., Volume 36 (2004), pp. 755-759","journal-title":"Nat. Genet."},{"key":"key2025102316374033925_43","doi-asserted-by":"crossref","first-page":"e13469","DOI":"10.1371\/journal.pone.0013469","article-title":"Transplantation of photoreceptor and total neural retina preserves cone function in P23H rhodopsin transgenic rat","volume":"5","author":"Yang, Y.","year":"2010","unstructured":"[43] Yang, Y. et al. Transplantation of photoreceptor and total neural retina preserves cone function in P23H rhodopsin transgenic rat, PloS one, Volume 5 (2010), p. e13469","journal-title":"PloS one"},{"key":"key2025102316374033925_44","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/mt.2009.28","article-title":"Functional cone rescue by RdCVF protein in a dominant model of retinitis pigmentosa","volume":"17","author":"Yang, Y.","year":"2009","unstructured":"[44] Yang, Y. et al. Functional cone rescue by RdCVF protein in a dominant model of retinitis pigmentosa, Mol. Ther., Volume 17 (2009), pp. 787-795","journal-title":"Mol. Ther."},{"key":"key2025102316374033925_45","author":"Byrne, L.","year":"2011","unstructured":"[45] Byrne, L. Engineered adeno-associated viral vectors for gene therapy in the retina, 2011","journal-title":"Engineered adeno-associated viral vectors for gene therapy in the retina"},{"key":"key2025102316374033925_46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/gt.2011.155","article-title":"Optogenetic therapy for retinitis pigmentosa","volume":"19","author":"Busskamp, V.","year":"2012","unstructured":"[46] Busskamp, V.; Picaud, S.; Sahel, J.A.; Roska, B. Optogenetic therapy for retinitis pigmentosa, Gene Ther., Volume 19 (2012), pp. 169-175","journal-title":"Gene Ther."},{"key":"key2025102316374033925_47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuron.2006.02.026","article-title":"Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration","volume":"50","author":"Bi, A.","year":"2006","unstructured":"[47] Bi, A. et al. Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration, Neuron, Volume 50 (2006), pp. 23-33","journal-title":"Neuron"},{"key":"key2025102316374033925_48","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nn.2117","article-title":"Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration","volume":"11","author":"Lagali, P.S.","year":"2008","unstructured":"[48] Lagali, P.S. et al. Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration, Nat. Neurosci., Volume 11 (2008), pp. 667-675","journal-title":"Nat. Neurosci."},{"key":"key2025102316374033925_49","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.1190897","article-title":"Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa","volume":"329","author":"Busskamp, V.","year":"2010","unstructured":"[49] Busskamp, V. et al. Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa, Science, Volume 329 (2010), pp. 413-417","journal-title":"Science"},{"key":"key2025102316374033925_50","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1523\/JNEUROSCI.0295-12.2012","article-title":"Emerging gene therapies for retinal degenerations","volume":"32","author":"Cepko, C.L.","year":"2012","unstructured":"[50] Cepko, C.L. Emerging gene therapies for retinal degenerations, J. Neurosci., Volume 32 (2012), pp. 6415-6420","journal-title":"J. Neurosci."},{"key":"key2025102316374033925_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2006.03.027","article-title":"Looking within for vision","volume":"50","author":"Flannery, J.G.","year":"2006","unstructured":"[51] Flannery, J.G.; Greenberg, K.P. Looking within for vision, Neuron, Volume 50 (2006), pp. 1-3","journal-title":"Neuron"},{"key":"key2025102316374033925_52","first-page":"1","article-title":"Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness","author":"Doroudchi, M.M.","year":"2009","unstructured":"[52] Doroudchi, M.M. et al. Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness, Mol. Ther. (2009), pp. 1-10","journal-title":"Mol. Ther."},{"key":"key2025102316374033925_53","article-title":"The implications of rod-dependent cone survival for basic and clinical research","author":"Hicks, D.","year":"1999","unstructured":"[53] Hicks, D.; Sahel, J. The implications of rod-dependent cone survival for basic and clinical research, Invest. Ophthalmol. Vis. Sci. (1999)","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"key2025102316374033925_54","first-page":"175","article-title":"Histopathology of the human retina in retinitis pigmentosa","volume":"17","author":"Milam, A.H.","year":"1998","unstructured":"[54] Milam, A.H.; Li, Z.Y.; Fariss, R.N. Histopathology of the human retina in retinitis pigmentosa, Prog. Retinal Eye Res., Volume 17 (1998), pp. 175-205","journal-title":"Prog. Retinal Eye Res."},{"key":"key2025102316374033925_55","first-page":"513","article-title":"Ultra light-sensitive and fast neuronal activation with the Ca<sup>2+<\/sup>-permeable channel rhodopsin CatCh","volume":"14","author":"Kleinlogel, S.","year":"2011","unstructured":"[55] Kleinlogel, S. et al. Ultra light-sensitive and fast neuronal activation with the Ca2+-permeable channel rhodopsin CatCh, Nat. Pub. Group, Volume 14 (2011), pp. 513-518","journal-title":"Nat. Pub. Group"},{"key":"key2025102316374033925_56","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/nn.3502","article-title":"ReaChR: a red-shifted variant of channel rhodopsin enables deep transcranial optogenetic excitation","volume":"16","author":"Lin, J.Y.","year":"2013","unstructured":"[56] Lin, J.Y.; Knutsen, P.M.; Muller, A.; Kleinfeld, D.; Tsien, R.Y. ReaChR: a red-shifted variant of channel rhodopsin enables deep transcranial optogenetic excitation, Nature Neurosci., Volume 16 (2013), pp. 1499-1508","journal-title":"Nature Neurosci."},{"key":"key2025102316374033925_57","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/cge.12165","article-title":"Retinal optogenetic therapies: clinical criteria for candidacy","volume":"84","author":"Jacobson, S.G.","year":"2013","unstructured":"[57] Jacobson, S.G.; Sumaroka, A.; Luo, X.; Cideciyan, A.V. Retinal optogenetic therapies: clinical criteria for candidacy, Clin. Genet., Volume 84 (2013), pp. 175-182","journal-title":"Clin. Genet."}],"container-title":["Comptes Rendus. Biologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/comptes-rendus.academie-sciences.fr\/biologies\/item\/10.1016\/j.crvi.2014.01.002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T14:51:29Z","timestamp":1761231089000},"score":1,"resource":{"primary":{"URL":"https:\/\/comptes-rendus.academie-sciences.fr\/biologies\/articles\/10.1016\/j.crvi.2014.01.002\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,1]]},"references-count":57,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014]]}},"alternative-id":["10.1016\/j.crvi.2014.01.002"],"URL":"https:\/\/doi.org\/10.1016\/j.crvi.2014.01.002","relation":{},"ISSN":["1631-0691","1768-3238"],"issn-type":[{"value":"1631-0691","type":"print"},{"value":"1768-3238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene therapy for inherited retinal degenerations","name":"articletitle","label":"Article Title"},{"value":"Comptes Rendus Biologies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crvi.2014.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Acad\u00e9mie des sciences. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}